CARDIAC DRUGS + CARDIOVASCULAR DRUGS (PHARMACY)
-
BTPHARMACEUTICAL DRUG CLASSIFICATION ACCORDING TO MAIN EFFECTS
-
UDC615.22
-
Descriptor GERHERZMITTEL + KREISLAUFMITTEL (PHARMAZIE)
-
Descriptor ENGCARDIAC DRUGS + CARDIOVASCULAR DRUGS (PHARMACY)
-
Descriptor FREMÉDICAMENTS CARDIOVASCULAIRES + MÉDICAMENTS CARDIAQUES (PHARMACIE)
-
Variant GERARZNEIMITTEL/HERZ- UND KREISLAUFWIRKSAME ARZNEIMITTEL (PHARMAZIE)
-
Variant GERMEDIKAMENTE/HERZ- UND KREISLAUFWIRKSAME MEDIKAMENTE (PHARMAZIE)
-
Variant GERBLUTKREISLAUF/ARZNEIMITTEL AUF DEN BLUTKREISLAUF WIRKENDE ARZNEIMITTEL (PHARMAZIE)
-
Variant GERKREISLAUFMITTEL (PHARMAZIE)
-
Variant GERHERZ-KREISLAUFMITTEL (PHARMAZIE)
-
Variant GERKARDIOVASKULÄRE ARZNEIMITTEL (PHARMAZIE)
-
Variant ENGCARDIOVASCULAR DRUGS (PHARMACY)
-
Variant ENGCARDIAC DRUGS (PHARMACY)
-
Variant ENGDRUGS/HEART AND BLOOD CIRCULATION AFFECTING DRUGS (PHARMACY)
-
Variant ENGMEDICAMENTS/HEART AND BLOOD CIRCULATION AFFECTING MEDICAMENTS (PHARMACY)
-
Variant ENGBLOOD CIRCULATION/DRUGS AFFECTING THE BLOOD CIRCULATION (PHARMACY)
-
Variant FREMÉDICAMENTS CARDIAQUES (PHARMACIE)
-
NTVASOACTIVE DRUGS (PHARMACY)
-
NTCARDIAC DEPRESSANTS + ANTIARRHYTHMIC DRUGS (PHARMACY)
-
NTCARDIOPROTECTIVE PHARMACEUTICAL DRUGS
-
NTCARDIOTONICS + CARDIOVASCULAR ANALEPTICS + MYOCARDIOTONICS (PHARMACY)
-
NTCORONARY DRUGS + CORONARY VASODILATORS (PHARMACY)